journal article·2025-12Open access

Synergistic Combination of Tamoxifen–Tetraphenylethylene Co‐Assembled Micelles and Orlistat‐Induced Lipid Droplet Inhibition to Overcome Tamoxifen Resistance

Jung Yeon Park, Jeehee Lee, Young Yong Kim, Sanghee Lee, Yongju Kim

Advanced Healthcare Materials· Volume 14· Issue 32

Abstract

Abstract Nanostructured supramolecular materials enable the precise control of biological interactions by tuning structural features such as size, shape, and surface charge, allowing targeted cellular uptake, optimized biodistribution, and enhance therapeutic efficacy. Despite its clinical success, tamoxifen (TMX) therapy faces challenges, such as drug resistance development; a key resistance mechanism involves intracellular lipid alterations. Lipid droplets (LD) play a crucial role in cancer progression and resistance to therapy. However, the direct suppression of LD formation as a synergistic adjunct to enhance TMX delivery remains underexplored. In this study, a supramolecular micelle platform based on amphiphilic tetraphenylethylene derivatives are presented with tunable oligoethylene glycol (OEG) side‐chain lengths. By modulating the OEG length, micelles with distinct surface charges are developed that significantly improve intracellular the TMX delivery to LDs. Furthermore, this system enabled visualization of intracellular drug distribution via intrinsic fluorescence. This targeted delivery reveales that LD‐mediated TMX sequestration is a resistance mechanism in estrogen receptor‐positive breast cancer. Importantly, co‐treatment with orlistat, an LD formation inhibitor, disrupted this resistance pathway and markedly enhance TMX efficacy of TMX. This dual‐functional approach, combining organelle‐specific delivery and LD modulation, constitutes a powerful supramolecular strategy to overcome TMX resistance and advances the development of next‐generation cancer therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lipid metabolism and biosynthesis · Enzyme Catalysis and Immobilization · Edible Oils Quality and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

KU‐KIST Graduate School of Converging Science and Technology Korea University Seoul 02841 Republic of Korea

Biomedical Research Division, Medicinal Materials Research Center Korea Institute of Science and Technology Seoul 02792 Republic of Korea

Department of HY‐KIST Bio‐convergence Hanyang University Seoul 04763 Republic of Korea

Beamline division, Pohang Accelerator Laboratory Pohang University of Science and Technology Pohang 37673 Republic of Korea

KHU‐KIST Department of Converging Science and Technology Hanyang University Seoul 02453 Republic of Korea

Department of Integrative Energy Engineering Korea University Seoul 02841 Republic of Korea

Chemical and Biological Integrative Research Center Korea Institute of Science and Technology Seoul 02792 Republic of Korea

Funding

National Research Foundation of Korea

References (41)

Show source-provided references
1. 10.1039/D0MA00807A10.1039/D0MA00807A ↗
2. 10.3389/fmicb.2023.115562210.3389/fmicb.2023.1155622 ↗
3. 10.1002/adma.20200240510.1002/adma.202002405 ↗
4. 10.1002/adma.20190566910.1002/adma.201905669 ↗
5. 10.1021/acsami.2c0292210.1021/acsami.2c02922 ↗
6. 10.1002/adhm.20250018910.1002/adhm.202500189 ↗
7. 10.1021/jacs.2c1093810.1021/jacs.2c10938 ↗
8. 10.1016/j.ijpharm.2024.12479910.1016/j.ijpharm.2024.124799 ↗
9. 10.1080/10717544.2019.158273010.1080/10717544.2019.1582730 ↗
10. 10.1021/acsnano.3c0585310.1021/acsnano.3c05853 ↗
11. 10.1016/j.bioactmat.2022.12.02710.1016/j.bioactmat.2022.12.027 ↗
12. 10.3390/jpm1108080810.3390/jpm11080808 ↗
13. 10.1016/j.pbiomolbio.2025.05.00210.1016/j.pbiomolbio.2025.05.002 ↗
14. 10.7150/ijbs.10536110.7150/ijbs.105361 ↗
15. 10.1016/j.ccr.2023.21533710.1016/j.ccr.2023.215337 ↗
16. 10.1038/s41467-022-33299-510.1038/s41467-022-33299-5 ↗
17. 10.1186/s12964-023-01178-110.1186/s12964-023-01178-1 ↗
18. 10.3390/nu1106119910.3390/nu11061199 ↗
19. 10.1002/adma.20210232210.1002/adma.202102322 ↗
20. 10.3390/ma1109176810.3390/ma11091768 ↗
21. 10.1016/j.trac.2024.11770310.1016/j.trac.2024.117703 ↗
22. 10.1002/adom.20200111910.1002/adom.202001119 ↗
23. 10.1002/anie.20210416310.1002/anie.202104163 ↗
24. 10.1021/jacs.0c1232310.1021/jacs.0c12323 ↗
25. 10.1002/ange.20211105210.1002/ange.202111052 ↗
26. 10.1021/acsami.3c1454710.1021/acsami.3c14547 ↗
27. 10.1016/j.jconrel.2021.03.01310.1016/j.jconrel.2021.03.013 ↗
28. 10.1149/07515.0239ecst10.1149/07515.0239ecst ↗
29. 10.1039/b822560e10.1039/b822560e ↗
30. 10.1039/C8QM00062J10.1039/C8QM00062J ↗
31. 10.1016/j.xpro.2024.10297710.1016/j.xpro.2024.102977 ↗
32. 10.1002/1873-3468.1479210.1002/1873-3468.14792 ↗
33. 10.1002/hep.2381310.1002/hep.23813 ↗
34. 10.1016/j.chemosphere.2019.12470510.1016/j.chemosphere.2019.124705 ↗
35. 10.1021/acs.analchem.2c0423010.1021/acs.analchem.2c04230 ↗
36. 10.1002/adma.20210062910.1002/adma.202100629 ↗
37. 10.1016/j.jconrel.2022.09.04510.1016/j.jconrel.2022.09.045 ↗
38. 10.1016/j.sbi.2022.10242710.1016/j.sbi.2022.102427 ↗
39. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
40. 10.1186/s13045-023-01498-210.1186/s13045-023-01498-2 ↗
41. 10.1016/j.devcel.2021.04.01310.1016/j.devcel.2021.04.013 ↗